NCT04966702View on ClinicalTrials.gov

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

48,145

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

April 15, 2024

Study Completion Date

October 3, 2024

Conditions
Malaria
Interventions
DRUG

Albendazole Pill

Using a MDA approach, fieldworkers will administer albendazole using directly observed treatment methodology to participants

DRUG

Ivermectin Pill

Using a MDA approach, fieldworkers will administer ivermectin using directly observed treatment methodology to participants

DRUG

Ivermectin Injectable Product

Veterinary ivermectin injectable will be given to livestock in the relevant cluster

Trial Locations (2)

90100

KEMRI, Kwale

Unknown

CISM, Mopeia

All Listed Sponsors
collaborator

UNITAID

OTHER

lead

Barcelona Institute for Global Health

OTHER